WILLIAM E. MCLAUGHLIN, III

Corporate Board Profile

Tech Score: 0/100

Fuse Medical, Inc.

Filing Date	Source Excerpt
2020-04-27	Mr. McLaughlin has served as a member of our Board since December 19, 2016, as Interim Chief Financial Officer from March 31, 2017, until January 18, 2018, when our Board appointed Mr. McLaughlin to his current position of Chief Financial Officer and Treasurer. ... Our entire Board serves as the audit committee of our Company. William E. McLaughlin, III serves as our "audit committee financial expert" ... 2019 Summary Compensation Table for Named Executive Officers shows total compensation for Mr. McLaughlin as $200,000.
2021-04-27	Mr. McLaughlin has served as a member of our Board since December 19, 2016, as Interim Chief Financial Officer from March 31, 2017 until January 18, 2018, when our Board appointed Mr. McLaughlin, to his current position of Chief Financial Officer and Treasurer. Mr. McLaughlin is a certified public accountant licensed in the State of Texas and has over 26 years of experience in accounting and financial reporting for private and large public companies traded on the New York Stock Exchange ("NYSE") and NASDAQ Stock Market ("NASDAQ") in addition to his work for "big-four" public accounting firms. Mr. McLaughlin has also served as Chief Financial Officer of CPM since 2014 and Maxim since 2018. Mr. McLaughlin joined CPM as Vice President Finance, Controller in 2013. From 2006 until he joined CPM, Mr. McLaughlin served as Vice President Finance, Controller for Caris Life Sciences, Inc., a $180 million international, anatomic pathology, and molecular biotechnology laboratories and multi-state physician practices enterprise. Having over 26 years of experience in accounting and financial reporting for private and public companies, Mr. McLaughlin brings considerable financial expertise to our Board.

Filing Date

Source Excerpt

2020-04-27

Mr. McLaughlin has served as a member of our Board since December 19, 2016, as Interim Chief Financial Officer from March 31, 2017, until January 18, 2018, when our Board appointed Mr. McLaughlin to his current position of Chief Financial Officer and Treasurer. ... Our entire Board serves as the audit committee of our Company. William E. McLaughlin, III serves as our "audit committee financial expert" ... 2019 Summary Compensation Table for Named Executive Officers shows total compensation for Mr. McLaughlin as $200,000.

2021-04-27

Mr. McLaughlin has served as a member of our Board since December 19, 2016, as Interim Chief Financial Officer from March 31, 2017 until January 18, 2018, when our Board appointed Mr. McLaughlin, to his current position of Chief Financial Officer and Treasurer. Mr. McLaughlin is a certified public accountant licensed in the State of Texas and has over 26 years of experience in accounting and financial reporting for private and large public companies traded on the New York Stock Exchange ("NYSE") and NASDAQ Stock Market ("NASDAQ") in addition to his work for "big-four" public accounting firms. Mr. McLaughlin has also served as Chief Financial Officer of CPM since 2014 and Maxim since 2018. Mr. McLaughlin joined CPM as Vice President Finance, Controller in 2013. From 2006 until he joined CPM, Mr. McLaughlin served as Vice President Finance, Controller for Caris Life Sciences, Inc., a $180 million international, anatomic pathology, and molecular biotechnology laboratories and multi-state physician practices enterprise. Having over 26 years of experience in accounting and financial reporting for private and public companies, Mr. McLaughlin brings considerable financial expertise to our Board.

Data sourced from SEC filings. Last updated: 2025-10-11